Values Added Financial LLC Acquires Shares of 1,421 iShares Biotechnology ETF (NASDAQ:IBB)

Values Added Financial LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 1,421 shares of the financial services provider’s stock, valued at approximately $207,000.

A number of other large investors have also added to or reduced their stakes in IBB. Williams Financial LLC bought a new position in iShares Biotechnology ETF in the 2nd quarter worth $867,000. PVG Asset Management Corp bought a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $415,000. Oppenheimer & Co. Inc. lifted its stake in shares of iShares Biotechnology ETF by 7.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock valued at $4,905,000 after purchasing an additional 2,532 shares during the period. PFG Advisors lifted its position in iShares Biotechnology ETF by 3.9% during the first quarter. PFG Advisors now owns 4,655 shares of the financial services provider’s stock valued at $639,000 after buying an additional 173 shares during the period. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of iShares Biotechnology ETF by 113.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 946 shares of the financial services provider’s stock valued at $130,000 after buying an additional 502 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.6 %

NASDAQ IBB traded up $2.18 during trading hours on Friday, reaching $142.47. 335,515 shares of the company’s stock traded hands, compared to its average volume of 1,443,860. iShares Biotechnology ETF has a 52-week low of $113.56 and a 52-week high of $150.57. The firm has a 50-day simple moving average of $145.24 and a 200 day simple moving average of $140.27.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.